• Home
  • All News Articles
  • UNC spinoff working to bring customizable infertility treatment to market with 3D printed IVRs
Rahima Benhabbour, PhD

AnelleO, a UNC spinoff company, is working to make a customizable drug-delivery platform for women a reality with their first product – AnelleO PRO, a progesterone-releasing intravaginal ring for treatment of infertility. AnelleO was co-founded by Rahima Benhabbour, PhD and Rima Janusziewicz, PhD.

Benhabbour, an Assistant Professor in the UNC/NC State Joint Department of Biomedical Engineering and an NC TraCS KL2 Scholar (2015-2017), has continued her work on 3D printed intravaginal rings as a customizable drug-delivery platform that was supported in its early stages by TraCS pilot funding and continued during her time as a TraCS KL2 Scholar.

Janusziewicz developed expertise in 3D printing during graduate training and was chosen as a MOTRD UP postdoctoral fellow mentored by Benhabbour through our CTSA-funded TL1 Program to learn about commercialization and regulatory approaches to product development.

Read more at innovate.unc.edu and wraltechwire.com.

NC TraCS Institute logo vertical

In partnership with:

Contact Us


Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social


Cite Us


CitE and SUBMit CTSA Grant number - UM1TR004406

© 2008-2024 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact